This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mattana, A.
Right arrow Articles by Cappuccinelli, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mattana, A.
Right arrow Articles by Cappuccinelli, P.

 Previous Article  |  Next Article 

Antimicrobial Agents and Chemotherapy, December 2004, p. 4520-4527, Vol. 48, No. 12
0066-4804/04/$08.00+0     DOI: 10.1128/AAC.48.12.4520-4527.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.

In Vitro Evaluation of the Effectiveness of the Macrolide Rokitamycin and Chlorpromazine against Acanthamoeba castellanii

A. Mattana,1* G. Biancu,1 L. Alberti,1 A. Accardo,1 G. Delogu,2 P. L. Fiori,2 and P. Cappuccinelli2

Department of Pharmaceutical Sciences,1 Department of Biomedical Sciences, Division of Experimental and Clinical Microbiology, University of Sassari, Sassari, Italy2

Received 5 May 2004/ Returned for modification 3 June 2004/ Accepted 27 July 2004

The present study demonstrates the in vitro effectiveness of the macrolide rokitamycin and the phenothiazine compound chlorpromazine against Acanthamoeba castellanii. Growth curve evaluations revealed that both drugs inhibit trophozoite growth in dose- and time-dependent ways. The effects of both drugs when they were used at the MICs at which 100% of isolates are inhibited were amoebistatic, but at higher doses they were amoebicidal as well as cysticidal. Experiments showed that when rokitamycin was associated with chlorpromazine or amphotericin B, rokitamycin enhanced their activities. Furthermore, low doses of rokitamycin and chlorpromazine, alone or in combination, blocked the cytopathic effect of A. castellanii against WKD cells derived from the human cornea. These results may have important significance in the development of new anti-Acanthamoeba compounds.

* Corresponding author. Mailing address: Dipartimento di Scienze del Farmaco, Via Muroni 23/A, 07100 Sassari, Italy. Phone: 39-079-228744. Fax: 39-079-228712. E-mail: dsfanto{at}uniss.it.

Antimicrobial Agents and Chemotherapy, December 2004, p. 4520-4527, Vol. 48, No. 12
0066-4804/04/$08.00+0     DOI: 10.1128/AAC.48.12.4520-4527.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.



This article has been cited by other articles:

  • Kim, J.-H., Jung, S.-Y., Lee, Y.-J., Song, K.-J., Kwon, D., Kim, K., Park, S., Im, K.-I., Shin, H.-J. (2008). Effect of Therapeutic Chemical Agents In Vitro and on Experimental Meningoencephalitis Due to Naegleria fowleri. Antimicrob. Agents Chemother. 52: 4010-4016 [Abstract] [Full Text]  
  • Bouyer, S., Imbert, C., Daniault, G., Cateau, E., Rodier, M.-H. (2007). Effect of caspofungin on trophozoites and cysts of three species of Acanthamoeba. J Antimicrob Chemother 59: 122-124 [Abstract] [Full Text]  
  • Fiori, P. L., Mattana, A., Dessi, D., Conti, S., Magliani, W., Polonelli, L. (2006). In vitro acanthamoebicidal activity of a killer monoclonal antibody and a synthetic peptide. J Antimicrob Chemother 57: 891-898 [Abstract] [Full Text]  


Copyright © 2010 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»